🇺🇸 FDA
Pipeline program

Dysport Placebo Solution for injection, Botulinum Toxin Type A 300 units Powder for solution for injection, Botulinum Toxin Type A 500 units Powder for solution for injection

CLIN-52120-464

Phase 3 small_molecule active

Quick answer

Dysport Placebo Solution for injection, Botulinum Toxin Type A 300 units Powder for solution for injection, Botulinum Toxin Type A 500 units Powder for solution for injection for Episodic Migraine is a Phase 3 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Ipsen Pharma
Indication
Episodic Migraine
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials